Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Sort descending Original Publication Date Journal Bone Marrow Disease
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity International Journal of Hematology Myelodysplastic Syndromes (MDS)
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity International Journal of Hematology Myelodysplastic Syndromes (MDS)
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag Leukemia Aplastic Anemia
Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter? Expert Review of Hematology Myelodysplastic Syndromes (MDS)
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties American Journal of Hematology Aplastic Anemia
How I Diagnose Low-Grade Myelodysplastic Syndromes American Journal of clinical Pathology Myelodysplastic Syndromes (MDS)
How I Treat Paroxysmal nocturnal hemoglobinuria Blood Paroxysmal Nocturnal Hemoglobinuria (PNH)
How we diagnose Myelodysplastic syndromes Frontiers in Oncology Myelodysplastic Syndromes (MDS)
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities Clinical Lymphoma , Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Haematologica Aplastic Anemia

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.